Robin Cornelissen

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. doi request reprint Dendritic cell-based immunotherapy in mesothelioma
    Robin Cornelissen
    Department of Pulmonary Medicine, Erasmus MC, SV 125, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Immunotherapy 4:1011-22. 2012
  2. pmc New roads open up for implementing immunotherapy in mesothelioma
    R Cornelissen
    Department of Pulmonary Medicine, Erasmus Medical Center Daniel den Hoed Cancer Center, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Clin Dev Immunol 2012:927240. 2012
  3. pmc Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma
    Robin Cornelissen
    Dept of Pulmonary Diseases, Sint Franciscus Gasthuis, Rotterdam, The Netherlands
    Radiat Oncol 2:2. 2007
  4. pmc Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma
    Robin Cornelissen
    Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
    PLoS ONE 9:e106742. 2014
  5. pmc Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment
    Marlies E Heuvers
    Department of Pulmonary Medicine, Erasmus Medical Center, Postbox 2040, 3000 CA, Rotterdam, The Netherlands
    BMC Cancer 12:580. 2012

Detail Information

Publications5

  1. doi request reprint Dendritic cell-based immunotherapy in mesothelioma
    Robin Cornelissen
    Department of Pulmonary Medicine, Erasmus MC, SV 125, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Immunotherapy 4:1011-22. 2012
    ..This review gives an update and provides a future perspective in which immunotherapy may improve the outcome of mesothelioma therapy...
  2. pmc New roads open up for implementing immunotherapy in mesothelioma
    R Cornelissen
    Department of Pulmonary Medicine, Erasmus Medical Center Daniel den Hoed Cancer Center, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Clin Dev Immunol 2012:927240. 2012
    ..We will provide possible strategies and discuss opportunities to overcome these problems...
  3. pmc Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma
    Robin Cornelissen
    Dept of Pulmonary Diseases, Sint Franciscus Gasthuis, Rotterdam, The Netherlands
    Radiat Oncol 2:2. 2007
    ..This report provides guidelines for the evaluation and treatment of patients with pulmonary infiltrates after radiotherapy...
  4. pmc Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma
    Robin Cornelissen
    Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
    PLoS ONE 9:e106742. 2014
    ..We analyzed if the macrophage count and the M2 to total macrophage ratio is a discriminative marker for outcome after surgery in malignant pleural mesothelioma (MPM) and studied the prognostic value of these immunological cells...
  5. pmc Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment
    Marlies E Heuvers
    Department of Pulmonary Medicine, Erasmus Medical Center, Postbox 2040, 3000 CA, Rotterdam, The Netherlands
    BMC Cancer 12:580. 2012
    ....